INVEGA SUSTENNA® Common Dosing and Administration Topics
Specific Populations
Hepatic Impairment
Consistent with the INVEGA SUSTENNA® Prescribing Information:
- INVEGA SUSTENNA® has not been studied in patients with hepatic impairment. Based on a study with oral paliperidone, no dose adjustment is required in patients with mild or moderate hepatic impairment. Paliperidone has not been studied in patients with severe hepatic impairment.